Clinical Trials Directory

Trials / Completed

CompletedNCT03563521

Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma

Serum Cytokine Profiles of Severe Asthma

Status
Completed
Phase
Study type
Observational
Enrollment
95 (actual)
Sponsor
TC Erciyes University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to determine and compare serum cytokine levels of six different severe asthma inflammatory phenotypes differentiated by their atopy, peripheral eosinophilia and/or chronic rhinosinusitis and/or nasal polyposis status.

Detailed description

A prospective observational study of 90 adults diagnosed with severe asthma and on regular follow-up and 15 control subjects will be investigated. Stable (controlled or partly-controlled) status (of all) and exacerbated-status (if any) serum cytokine levels \[IL-4, IL-5, IL-10, IL-13, IL-25, IL-33, thymic stromal lymphopoietin (TSLP), IL-17A, periostin) will be evaluated. Also nasopharyngeal brush samples will be obtained for respiratory tract panel work-up with PCR in exacerbated patients. Effect of viral infections' on cytokine response in different inflammatory phenotypes will be evaluated.

Conditions

Timeline

Start date
2017-11-27
Primary completion
2019-02-01
Completion
2019-06-28
First posted
2018-06-20
Last updated
2019-07-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03563521. Inclusion in this directory is not an endorsement.